Morbo di Halzheimer

• The therapeutic potential of the endocannabinoid system for Alzheimer’s disease (PubMed)
• Endocannabinoid signalling in Alzheimer’s disease (PubMed)
• A molecular link between the active component of marijuana and Alzheimer’s disease pathology (PubMed)
• Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells (PubMed)
• The Potential Therapeutic Effects of THC on Alzheimer’s Disease (PubMed)
• The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease (PubMed)
• Cannabinoids for the treatment of dementia (PubMed)
• Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression (PubMed)
• Cannabidiol: A promising drug for neurodegenerative disorders? (PubMed)
• Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition (PubMed)
• The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses(PubMed)
• The role of phytochemicals in the treatment and prevention of dementia (PubMed)
• Cannabinoids for the treatment of dementia (PubMed)
• Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement (PubMed)
• Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic (Pub Med)
• Can Marijuana Prevent Alzheimer’s? (Next Avenue)